BMPR1A and Hepatic fibrosis: In summary, autocrine GDF10 activates BMPR2/ALK3‐SMAD1/5/8‐SMAD7 pathway to counteract the TGF‐β‐SMAD2/3 pathway in HSCs, thereby inhibiting HSC activation and preventing liver fibrosis (Figure 8Q).